June 13 (Reuters) – KemPharm Inc said the U.S.
health regulator did not approve its abuse-deterrent version of
a painkiller, sending the drug developer’s shares down more than
30 pct in extended…
The post KemPharm says U.S. FDA does not approve its painkiller appeared first on NASDAQ.